Search research articles
Contact Us
Filters
Showing results (281-290 of 329) with videos related to
Page
of 33
Sort By:
Journal of the American College of Cardiology
|
March 29, 2020
Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time
Peter J McCartney, Annette M Maznyczka, Hany Eteiba, et al.
Circulation
|
May 13, 2021
Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction
Kieran F Docherty, Ross T Campbell, Katriona J M Brooksbank, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 18, 2018
Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial Infarction
David Carrick, Caroline Haig, Annette M Maznyczka, et al.
JACC. Cardiovascular Imaging
|
July 23, 2018
Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights
Caroline Haig, David Carrick, Jaclyn Carberry, et al.
The Lancet Regional Health. Europe
|
December 27, 2024
Maternal and pregnancy factors contributing to the association between area deprivation and infant mortality in England: a retrospective cohort study
Frederick K Ho, Max Allan, Hui Shao, et al.
JAMA
|
June 23, 2011
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
David Preiss, Sreenivasa Rao Kondapally Seshasai, Paul Welsh, et al.
Diabetes Care
|
December 20, 2019
Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank
Claire Welsh, Paul Welsh, Carlos A Celis-Morales, et al.
Circulation
|
November 8, 2021
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial
David D Berg, Kieran F Docherty, Naveed Sattar, et al.
Journal of Cardiac Failure
|
August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trial
David D Berg, Kieran Docherty, Atefeh Talebi, et al.
ESC Heart Failure
|
May 8, 2024
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design
Jaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Page
of 33
Search research articles
Search
Showing results (281-290 of 329) with videos related to
Sort By:
Page
of 33
Journal of the American College of Cardiology
|
March 29, 2020
Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time
Peter J McCartney, Annette M Maznyczka, Hany Eteiba, et al.
Circulation
|
May 13, 2021
Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction
Kieran F Docherty, Ross T Campbell, Katriona J M Brooksbank, et al.
Hypertension (Dallas, Tex. : 1979)
|
July 18, 2018
Hypertension, Microvascular Pathology, and Prognosis After an Acute Myocardial Infarction
David Carrick, Caroline Haig, Annette M Maznyczka, et al.
JACC. Cardiovascular Imaging
|
July 23, 2018
Current Smoking and Prognosis After Acute ST-Segment Elevation Myocardial Infarction: New Pathophysiological Insights
Caroline Haig, David Carrick, Jaclyn Carberry, et al.
The Lancet Regional Health. Europe
|
December 27, 2024
Maternal and pregnancy factors contributing to the association between area deprivation and infant mortality in England: a retrospective cohort study
Frederick K Ho, Max Allan, Hui Shao, et al.
JAMA
|
June 23, 2011
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
David Preiss, Sreenivasa Rao Kondapally Seshasai, Paul Welsh, et al.
Diabetes Care
|
December 20, 2019
Glycated Hemoglobin, Prediabetes, and the Links to Cardiovascular Disease: Data From UK Biobank
Claire Welsh, Paul Welsh, Carlos A Celis-Morales, et al.
Circulation
|
November 8, 2021
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients With Heart Failure With Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial
David D Berg, Kieran F Docherty, Naveed Sattar, et al.
Journal of Cardiac Failure
|
August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trial
David D Berg, Kieran Docherty, Atefeh Talebi, et al.
ESC Heart Failure
|
May 8, 2024
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design
Jaclyn Carberry, Mark C Petrie, Matthew M Y Lee, et al.
Page
of 33